Company intelligence / Profile preview
Salud Care
- Ownership
- Private
- Development stage
- Other
Overview
Salud Care has established itself as a global manufacturer and supplier of over 950 pharmaceutical drug combinations, with key strengths in cardiovascular, antidiabetic, and dermatology segments. It supplies both branded and generic medications, is PIC/S compliant, and distributes to over 50 countries; revenue has surpassed ₹100 crore annually. The company is preparing for an IPO in late 2025.
- Therapeutic areas
- ImmunologyEndocrinologyMetabolic DisordersInfectious DiseasesGastroenterologyDermatologyPulmonologyCardiovascularNeurology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Salud Care.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Salud Care.